CANCER SUPPORT UK (CSUK)


CANCER SUPPORT UK (CSUK)

Company limited by guarantee

Company Registration Number:
05048319 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2021

Period of accounts

Start date: 1 January 2021

End date: 31 December 2021

CANCER SUPPORT UK (CSUK)

Contents of the Financial Statements

for the Period Ended 31 December 2021

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

CANCER SUPPORT UK (CSUK)

Directors' report period ended 31 December 2021

The directors present their report with the financial statements of the company for the period ended 31 December 2021

Principal activities of the company

CSUK’s principal objectives are, throughout the world:To relieve sickness and advance education, including in particular in relation to the provision of services and resources to meet medical,emotional, psychological, spiritual and other needs of individuals as a holistic approach to prevent and treat cancer and to relieve povertyand economic hardship associated with the experience of cancer.



Directors

The directors shown below have held office during the whole of the period from
1 January 2021 to 31 December 2021

Mr Matthew Doyle
Ms Julia Dawson
Mr Bryan Marcus
Ms Sarita Yaganti
Ms Sarah Elizabeth Mcdonald


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 September 2022

And signed on behalf of the board by:
Name: Mr Matthew Doyle
Status: Director

CANCER SUPPORT UK (CSUK)

Profit And Loss Account

for the Period Ended 31 December 2021

2021 2020


£

£
Turnover: 567,544 1,104,949
Cost of sales: ( 830,041 ) ( 637,602 )
Gross profit(or loss): (262,497) 467,347
Operating profit(or loss): (262,497) 467,347
Profit(or loss) before tax: (262,497) 467,347
Profit(or loss) for the financial year: (262,497) 467,347

CANCER SUPPORT UK (CSUK)

Balance sheet

As at 31 December 2021

Notes 2021 2020


£

£
Fixed assets
Tangible assets: 3 2,795 2,484
Total fixed assets: 2,795 2,484
Current assets
Debtors: 4 138,567 122,018
Cash at bank and in hand: 342,345 606,654
Total current assets: 480,912 728,672
Net current assets (liabilities): 480,912 728,672
Total assets less current liabilities: 483,707 731,156
Creditors: amounts falling due after more than one year: 5 ( 89,062 ) ( 74,014 )
Total net assets (liabilities): 394,645 657,142
Members' funds
Profit and loss account: 394,645 657,142
Total members' funds: 394,645 657,142

The notes form part of these financial statements

CANCER SUPPORT UK (CSUK)

Balance sheet statements

For the year ending 31 December 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 September 2022
and signed on behalf of the board by:

Name: Mr Matthew Doyle
Status: Director

The notes form part of these financial statements

CANCER SUPPORT UK (CSUK)

Notes to the Financial Statements

for the Period Ended 31 December 2021

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    The Board have agreed to set aside and ring fence ‘free reserves’ i.e. unrestricted funds, not committed or invested in tangible fixed assets, which equates to three months of the current year budgeted operational overheads. This will be held in a separate bank/instant accesssavings account (potentially interest earning) and would not be accessed without the specific prior agreement of the Board of Trustees.In addition, unrestricted cash in CSUK’s transactional bank account is controlled at a level that equates to a minimum of three months anda maximum of six months cover of the current year budgeted operational overheads.This policy is reviewed on an annual basis when conducting the annual audit and agreeing the year-end financial statements.

CANCER SUPPORT UK (CSUK)

Notes to the Financial Statements

for the Period Ended 31 December 2021

  • 2. Employees

    2021 2020
    Average number of employees during the period 8 6

CANCER SUPPORT UK (CSUK)

Notes to the Financial Statements

for the Period Ended 31 December 2021

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 January 2021 3,915 3,915
Additions 1,142 1,142
Disposals
Revaluations
Transfers
At 31 December 2021 5,057 5,057
Depreciation
At 1 January 2021 1,431 1,431
Charge for year 831 831
On disposals
Other adjustments
At 31 December 2021 2,262 2,262
Net book value
At 31 December 2021 2,795 2,795
At 31 December 2020 2,484 2,484

CANCER SUPPORT UK (CSUK)

Notes to the Financial Statements

for the Period Ended 31 December 2021

4. Debtors

2021 2020
£ £
Trade debtors 38,007 18,921
Prepayments and accrued income 74,222 73,748
Other debtors 26,338 29,349
Total 138,567 122,018

CANCER SUPPORT UK (CSUK)

Notes to the Financial Statements

for the Period Ended 31 December 2021

5. Creditors: amounts falling due after more than one year note

2021 2020
£ £
Other creditors 89,062 74,014
Total 89,062 74,014